Inactivation of cytomegalovirus in platelet concentrates using helinx™ technology
- 1 October 2001
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 38, 27-33
- https://doi.org/10.1016/s0037-1963(01)90121-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Intrauterine Transmission of Cytomegalovirus to Infants of Women with Preconceptional ImmunityNew England Journal of Medicine, 2001
- Transfusion-transmissible infectionsCurrent Opinion in Hematology, 1998
- Methods for the reduction of transfusion‐transmitted cytomegalovirus infection: filtration versus the use of seronegative donor unitsTransfusion, 1994
- CYTOMEGALOVIRUS INFECTION IN TRANSPLANT RECIPIENTS THE ROLE OF TUMOR NECROSIS FACTORTransplantation, 1994
- THE COST IMPACT OF CYTOMEGALOVIRUS DISEASE IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1993
- Prevention of transfusion-transmitted cytomegalovirus infectionTransfusion, 1992
- Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantationBlood, 1991
- Acquisition of cytomegalovirus infection: an updateClinical Microbiology Reviews, 1989
- SYMPTOMATIC CYTOMEGALOVIRUS INFECTION IN SEROPOSITIVE KIDNEY RECIPIENTS: REINFECTION WITH DONOR VIRUS RATHER THAN REACTIVATION OF RECIPIENT VIRUSThe Lancet, 1988
- Transfusion-associated Cytomegalovirus InfectionsClinical Infectious Diseases, 1983